» Articles » PMID: 35134561

Systematic Review and Meta-analysis of Olfactory and Gustatory Dysfunction in COVID-19

Overview
Publisher Elsevier
Date 2022 Feb 8
PMID 35134561
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chemosensory disorders associated with COVID-19 have been widely discussed during the pandemic. We performed a meta-analysis to assess the risk factors for olfactory and gustatory dysfunction in patients with COVID-19.

Methods: Three databases (PubMed, Embase, and Cochrane Library) were searched for studies published between December 1, 2019, and August 31, 2021. We selected random-effects model or fixed-effects model to pool data based on heterogeneity. The results were reported as odds ratios (ORs) or standardized mean differences (SMDs) and the corresponding 95% confidence intervals (CIs). Heterogeneity was reported as I.

Results: Twenty-six studies with a total of 13,813 patients were included. The pooled data indicated that sex (OR 1.47; 95% CI 0.93-2.31), age (SMD -5.80; 95% CI -13.35 to 1.75), smoking (OR 2.04; 95% CI 0.72-5.79), and comorbidity (OR 1.21; 95% CI 0.58-2.53) of patients with COVID-19 had no effect on gustatory dysfunction. Olfactory dysfunction was more likely to occur in older patients with COVID-19 (SMD, -5.22; 95% CI, -8.28 to -2.16). Patients with COVID-19 with nasal congestion (OR 3.41; 95% CI 2.30-5.06) and rhinorrhea (OR 2.35; 95% CI 1.60-3.45) were more prone to olfactory dysfunction.

Conclusion: These findings emphasize that older patients with COVID-19 are more likely to experience olfactory dysfunction. Symptoms of nasal congestion and rhinorrhea may affect the recognition of olfactory dysfunction.

Citing Articles

Post COVID-19 and Long COVID Symptoms in Otorhinolaryngology-A Narrative Review.

Guntinas-Lichius O, Bitter T, Takes R, Lee V, Saba N, Makitie A J Clin Med. 2025; 14(2).

PMID: 39860512 PMC: 11765628. DOI: 10.3390/jcm14020506.


Why dogs prefer zoomies to zoom and what it tells us about the importance of in-person meetings for learning and memory.

Coppin G, Onofrio M Cogn Process. 2024; 26(1):231-234.

PMID: 39400658 PMC: 11897111. DOI: 10.1007/s10339-024-01235-8.


Mapping the vast landscape of multisystem complications of COVID-19: Bibliometric analysis.

Zhu Y, Cao X, Ying R, Liu K, Chai Y, Luo M Heliyon. 2024; 10(9):e30760.

PMID: 38765136 PMC: 11098853. DOI: 10.1016/j.heliyon.2024.e30760.


Integrating the patient's voice into the research agenda for treatment of chemosensory disorders.

Murphy C, Dalton P, Boateng K, Hunter S, Silberman P, Trachtman J Chem Senses. 2024; 49.

PMID: 38761171 PMC: 11154145. DOI: 10.1093/chemse/bjae020.


Long-Term Taste and Smell Outcomes After COVID-19.

Sharetts R, Moein S, Khan R, Doty R JAMA Netw Open. 2024; 7(4):e247818.

PMID: 38652477 PMC: 11040410. DOI: 10.1001/jamanetworkopen.2024.7818.


References
1.
Desiato V, Levy D, Byun Y, Nguyen S, Soler Z, Schlosser R . The Prevalence of Olfactory Dysfunction in the General Population: A Systematic Review and Meta-analysis. Am J Rhinol Allergy. 2020; 35(2):195-205. DOI: 10.1177/1945892420946254. View

2.
Sheng W, Liu W, Wang J, Chang S, Chang S . Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan. J Formos Med Assoc. 2020; 120(1 Pt 2):311-317. PMC: 7574720. DOI: 10.1016/j.jfma.2020.10.003. View

3.
Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

4.
Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

5.
Soh S, See A, Teo N, Tan H, Palaniappan G, Lim M . Prevalence of olfactory and taste dysfunction in COVID-19 patients: a community care facility study. Eur Arch Otorhinolaryngol. 2021; 278(9):3375-3380. PMC: 7886642. DOI: 10.1007/s00405-021-06647-2. View